Biobanking Market Size to Hit Around USD 182 Bn by 2034

Biobanking Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Biobanking Market, By Product

7.1. Biobanking Market Revenue and Volume, by Product

7.1.1. Biobanking Equipment

7.1.1.1. Market Revenue and Volume Forecast

7.1.2. Biobanking Consumables

7.1.2.1. Market Revenue and Volume Forecast

7.1.3. Laboratory Information Management Systems

7.1.3.1. Market Revenue and Volume Forecast

Chapter 8. Global Biobanking Market, By Service

8.1. Biobanking Market Revenue and Volume, by Service

8.1.1. Biobanking & Repository

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Lab processing

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Qualification/ Validation

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Cold Chain Logistics

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Other Services

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Biobanking Market, By Biospecimen Type

9.1. Biobanking Market Revenue and Volume, by Biospecimen Type

9.1.1. Human Tissues

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Human Organs

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Stem Cells

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Other Biospecimens

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Biobanking Market, By Biobanks Type

10.1. Biobanking Market Revenue and Volume, by Biobanks Type

10.1.1. Physical/Real Biobanks

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Tissue Biobanks

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Population Based Biobanks

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Genetic (DNA/RNA)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Disease Based Biobanks

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Virtual Biobanks

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Biobanking Market, By Application

11.1. Biobanking Market Revenue and Volume, by Application

11.1.1. Therapeutics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Drug Discovery & Clinical Research

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Clinical Diagnostics

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Other Applications

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Biobanking Market, By Ownership

12.1. Biobanking Market Revenue and Volume, by Ownership

12.1.1. University Owned

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. National/Regional Agencies Owned

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Non-profit Organizations Owned

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Private Organization Owned

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Biobanking Market, By End-use

13.1. Biobanking Market Revenue and Volume, by End-use

13.1.1. Pharmaceutical & Biotechnology Companies

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. CROs & CMOs

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Academic & Research Institutes

13.1.3.1. Market Revenue and Volume Forecast

13.1.4. Hospitals

13.1.4.1. Market Revenue and Volume Forecast

Chapter 14. Global Biobanking Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Product

14.1.2. Market Revenue and Volume Forecast, by Service

14.1.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.1.4. Market Revenue and Volume Forecast, by Biobanks Type

14.1.5. Market Revenue and Volume Forecast, by Application

14.1.6. Market Revenue and Volume Forecast, by End-use

14.1.7. Market Revenue and Volume Forecast, by Ownership

14.1.8. U.S.

14.1.8.1. Market Revenue and Volume Forecast, by Product

14.1.8.2. Market Revenue and Volume Forecast, by Service

14.1.8.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.1.8.4. Market Revenue and Volume Forecast, by Biobanks Type

14.1.8.5. Market Revenue and Volume Forecast, by Application

14.1.8.6. Market Revenue and Volume Forecast, by End-use

14.1.8.7. Market Revenue and Volume Forecast, by Ownership

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Product

14.1.9.2. Market Revenue and Volume Forecast, by Service

14.1.9.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.1.9.4. Market Revenue and Volume Forecast, by Biobanks Type

14.1.9.5. Market Revenue and Volume Forecast, by Application

14.1.9.6. Market Revenue and Volume Forecast, by End-use

14.1.9.7. Market Revenue and Volume Forecast, by Ownership

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Product

14.2.2. Market Revenue and Volume Forecast, by Service

14.2.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.2.4. Market Revenue and Volume Forecast, by Biobanks Type

14.2.5. Market Revenue and Volume Forecast, by Application

14.2.6. Market Revenue and Volume Forecast, by End-use

14.2.7. Market Revenue and Volume Forecast, by Ownership

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Product

14.2.8.2. Market Revenue and Volume Forecast, by Service

14.2.8.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.2.8.4. Market Revenue and Volume Forecast, by Biobanks Type

14.2.8.5. Market Revenue and Volume Forecast, by Application

14.2.8.6. Market Revenue and Volume Forecast, by End-use

14.2.8.7. Market Revenue and Volume Forecast, by Ownership

14.2.9. Germany

14.2.9.1. Market Revenue and Volume Forecast, by Product

14.2.9.2. Market Revenue and Volume Forecast, by Service

14.2.9.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.2.9.4. Market Revenue and Volume Forecast, by Biobanks Type

14.2.9.5. Market Revenue and Volume Forecast, by Application

14.2.9.6. Market Revenue and Volume Forecast, by End-use

14.2.9.7. Market Revenue and Volume Forecast, by Ownership

14.2.10. France

14.2.10.1. Market Revenue and Volume Forecast, by Product

14.2.10.2. Market Revenue and Volume Forecast, by Service

14.2.10.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.2.10.4. Market Revenue and Volume Forecast, by Biobanks Type

14.2.10.5. Market Revenue and Volume Forecast, by Application

14.2.10.6. Market Revenue and Volume Forecast, by End-use

14.2.10.7. Market Revenue and Volume Forecast, by Ownership

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Volume Forecast, by Product

14.2.11.2. Market Revenue and Volume Forecast, by Service

14.2.11.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.2.11.4. Market Revenue and Volume Forecast, by Biobanks Type

14.2.11.5. Market Revenue and Volume Forecast, by Application

14.2.11.6. Market Revenue and Volume Forecast, by End-use

14.2.11.7. Market Revenue and Volume Forecast, by Ownership

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product

14.3.2. Market Revenue and Volume Forecast, by Service

14.3.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.3.4. Market Revenue and Volume Forecast, by Biobanks Type

14.3.5. Market Revenue and Volume Forecast, by Application

14.3.6. Market Revenue and Volume Forecast, by End-use

14.3.7. Market Revenue and Volume Forecast, by Ownership

14.3.8. India

14.3.8.1. Market Revenue and Volume Forecast, by Product

14.3.8.2. Market Revenue and Volume Forecast, by Service

14.3.8.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.3.8.4. Market Revenue and Volume Forecast, by Biobanks Type

14.3.8.5. Market Revenue and Volume Forecast, by Application

14.3.8.6. Market Revenue and Volume Forecast, by End-use

14.3.8.7. Market Revenue and Volume Forecast, by Ownership

14.3.9. China

14.3.9.1. Market Revenue and Volume Forecast, by Product

14.3.9.2. Market Revenue and Volume Forecast, by Service

14.3.9.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.3.9.4. Market Revenue and Volume Forecast, by Biobanks Type

14.3.9.5. Market Revenue and Volume Forecast, by Application

14.3.9.6. Market Revenue and Volume Forecast, by End-use

14.3.9.7. Market Revenue and Volume Forecast, by Ownership

14.3.10. Japan

14.3.10.1. Market Revenue and Volume Forecast, by Product

14.3.10.2. Market Revenue and Volume Forecast, by Service

14.3.10.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.3.10.4. Market Revenue and Volume Forecast, by Biobanks Type

14.3.10.5. Market Revenue and Volume Forecast, by Application

14.3.10.6. Market Revenue and Volume Forecast, by End-use

14.3.10.7. Market Revenue and Volume Forecast, by Ownership

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Volume Forecast, by Product

14.3.11.2. Market Revenue and Volume Forecast, by Service

14.3.11.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.3.11.4. Market Revenue and Volume Forecast, by Biobanks Type

14.3.11.5. Market Revenue and Volume Forecast, by Application

14.3.11.6. Market Revenue and Volume Forecast, by End-use

14.3.11.7. Market Revenue and Volume Forecast, by Ownership

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Product

14.4.2. Market Revenue and Volume Forecast, by Service

14.4.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.4.4. Market Revenue and Volume Forecast, by Biobanks Type

14.4.5. Market Revenue and Volume Forecast, by Application

14.4.6. Market Revenue and Volume Forecast, by End-use

14.4.7. Market Revenue and Volume Forecast, by Ownership

14.4.8. GCC

14.4.8.1. Market Revenue and Volume Forecast, by Product

14.4.8.2. Market Revenue and Volume Forecast, by Service

14.4.8.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.4.8.4. Market Revenue and Volume Forecast, by Biobanks Type

14.4.8.5. Market Revenue and Volume Forecast, by Application

14.4.8.6. Market Revenue and Volume Forecast, by End-use

14.4.8.7. Market Revenue and Volume Forecast, by Ownership

14.4.9. North Africa

14.4.9.1. Market Revenue and Volume Forecast, by Product

14.4.9.2. Market Revenue and Volume Forecast, by Service

14.4.9.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.4.9.4. Market Revenue and Volume Forecast, by Biobanks Type

14.4.9.5. Market Revenue and Volume Forecast, by Application

14.4.9.6. Market Revenue and Volume Forecast, by End-use

14.4.9.7. Market Revenue and Volume Forecast, by Ownership

14.4.10. South Africa

14.4.10.1. Market Revenue and Volume Forecast, by Product

14.4.10.2. Market Revenue and Volume Forecast, by Service

14.4.10.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.4.10.4. Market Revenue and Volume Forecast, by Biobanks Type

14.4.10.5. Market Revenue and Volume Forecast, by Application

14.4.10.6. Market Revenue and Volume Forecast, by End-use

14.4.10.7. Market Revenue and Volume Forecast, by Ownership

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Volume Forecast, by Product

14.4.11.2. Market Revenue and Volume Forecast, by Service

14.4.11.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.4.11.4. Market Revenue and Volume Forecast, by Biobanks Type

14.4.11.5. Market Revenue and Volume Forecast, by Application

14.4.11.6. Market Revenue and Volume Forecast, by End-use

14.4.11.7. Market Revenue and Volume Forecast, by Ownership

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Product

14.5.2. Market Revenue and Volume Forecast, by Service

14.5.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.5.4. Market Revenue and Volume Forecast, by Biobanks Type

14.5.5. Market Revenue and Volume Forecast, by Application

14.5.6. Market Revenue and Volume Forecast, by End-use

14.5.7. Market Revenue and Volume Forecast, by Ownership

14.5.8. Brazil

14.5.8.1. Market Revenue and Volume Forecast, by Product

14.5.8.2. Market Revenue and Volume Forecast, by Service

14.5.8.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.5.8.4. Market Revenue and Volume Forecast, by Biobanks Type

14.5.8.5. Market Revenue and Volume Forecast, by Application

14.5.8.6. Market Revenue and Volume Forecast, by End-use

14.5.8.7. Market Revenue and Volume Forecast, by Ownership

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Product

14.5.9.2. Market Revenue and Volume Forecast, by Service

14.5.9.3. Market Revenue and Volume Forecast, by Biospecimen Type

14.5.9.4. Market Revenue and Volume Forecast, by Biobanks Type

14.5.9.5. Market Revenue and Volume Forecast, by Application

14.5.9.6. Market Revenue and Volume Forecast, by End-use

14.5.9.7. Market Revenue and Volume Forecast, by Ownership

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Tecan Trading AG

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. QIAGEN

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Hamilton Company

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Brooks Life Sciences

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Brooks Life Sciences

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. TTP Labtech

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. VWR International, LLC.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Promega Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Worthington Industries

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biobanking market size was reached at USD 83.05 billion in 2024 and is anticipated to rake USD 182 billion by 2034.

The global biobanking market is growing at a CAGR of 8.16% from 2025 to 2034.

The major players in biobanking market are Thermo Fisher Scientific Inc., Tecan Trading AG, QIAGEN, Hamilton Company, Brooks Life Sciences, TTP Labtech, VWR International, LLC., Promega Corporation, Worthington Industries, BD, RUCDR Infinite Biologics, and Modul-Bio.

The rising investments on the drug discovery and drug development owing to the surging prevalence of chronic diseases such as Alzheimer’s and cancer among the global population is driving the growth of the biobanking market.

Europe was the leading biobanking market in 2024 and will lead in the near future.